Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 4, 2014, Pages 1212-1218

  Freeman, R ^a   Moore, L S P ^a,b   Charlett, A ^c   Donaldson, H ^b   Holmes, A H ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Microbiology; Resistance; Surveillance

Indexed keywords

CARBAPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; ENTEROBACTER; EPIDEMIOLOGY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; TEACHING HOSPITAL; UNITED KINGDOM; URINE CULTURE; CLASSIFICATION; DRUG EFFECTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; LONDON; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84926434524     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku500     Document Type: Article

References (23)

1. WHO. Antimicrobial Resistance: Global Report on Surveillance. Geneva: WHO, 2014. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf.
2. Patel G, Bonomo RA. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther 2011; 9: 555-70.
3. Giakoupi P, Maltezou H, Polemis et al. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 2009; 14: pii1/419218.
4. Woodford N, Tierno PM Jr, Young K et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 2004; 48: 4793-9.
5. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9:228-36.
6. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736-55.
7. Chief Medical Officer. Annual Report of the Chief Medical Officer (Volume Two): Infections and the Rise of Antimicrobial Resistance. London:Department of Health, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/138331/CMO_Annual_Report_Volume_2_2011.pdf.
8. CDC. Antibiotic Resistance Threats in the United States, 2013. Atlanta:CDC, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.
9. Department of Health. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. London: Department of Health, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf.
10. Schwaber MJ, Lev B, Israeli A et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52:848-55.
11. PHE. Acute Trust Toolkit for the Early Detection, Management and Control of Carbapenemase-Producing Enterobacteriaceae. London:PHE, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/329227/Acute_trust_toolkit_for_the_early_detection.pdf.
12. CDC. Guidance for Control of Carbapenem-resistant Enterobacteriaceae:2012 CRE Toolkit. Atlanta: CDC, 2012. http://www.cdc.gov/hai/pdfs/cre/cre-guidance-508.pdf.
13. Freeman R, Moore LS, Garcia AL et al. Advances in electronic surveillance for healthcare-associated infections in the 21st Century: a systematic review. J Hosp Infect 2013; 84: 106-19.
14. PHE. Standards for Microbiology Investigations. https://www.gov.uk/government/collections/standards-for-microbiology-investigations-smi.
15. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing: Version 12. http://bsac.org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013_final.pdf.
16. EUCAST. EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance:mechanisms/EUCAST_detection_of_resistance:mechanisms_v1.0_20131211.pdf.
17. HPA. Working Party Guidance on the Control of Multi-Resistant Acinetobacter Outbreaks. http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947325341.
18. Mammina C, Bonura C, Vivoli AR et al. Co-colonization with carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii in intensive care unit patients. Scand J Infect Dis 2013; 45:629-34.
19. PHE. UK Standards for Microbiology Investigations: Laboratory Detection and Reporting of Bacteria with Carbapenem-Hydrolysing b-Lactamases (Carbapenemases). https://www.gov.uk/government/publications/smi-p-8-laboratory-detection-and-reporting-of-bacteria-with-carbapenemhydrolysing-b-lactamases-carbapenemases.
20. Moore LS, Freeman R, GilchristMJ et al. Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial nonsusceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London. J Antimicrob Chemother 2014; 69: 3409-22.
21. Carvalhaes CG, Cayo R, Gales AC. Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the intensive care unit: a real challenge to physicians, scientific community, and society. Shock 2013; 39: 32-7.
22. Thaden JT, Lewis SS, Hazen KC et al. Rising rates of carbapenemresistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 2014; 35: 978-83.
23. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602.